Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats

International Braz J Urol

Volumn 41, Issue 2, 2015, Pages 279-287

  Otunctemur, Alper ^a   Ozbek, Emin ^b   Cakir, Suleyman Sami ^c   Dursun, Murat ^d   Cekmen, Mustafa ^e   Polat, Emre Can ^f   Ozcan, Levent ^g   Somay, Adnan ^h   Ozbay, Nurver ^h  

^a OKMEYDANI TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^c Bayburt State Hospital   (Turkey)

^d Erde Sokak   (Turkey)

^e KOCAELI UNIVERSITY   (Turkey)

^f ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

^g Department of Urology Derince Training and Research Hospital ^*  (Turkey)

^h FATIH SULTAN MEHMET TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cysteinyl leukotriene supplementary concept ; Montelukast supplementary concept ; Renal insufficiency; Ureteral obstruction

Indexed keywords

ACETIC ACID DERIVATIVE; CREATININE; CYSTEINE; CYSTEINYL-LEUKOTRIENE; GLUTATHIONE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MALONALDEHYDE; MONTELUKAST; NITRIC OXIDE; PROTECTIVE AGENT; QUINOLINE DERIVATIVE; UREA;

ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPLICATION; DRUG EFFECTS; FIBROSIS; KIDNEY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PATHOLOGY; RENAL INSUFFICIENCY; REPRODUCIBILITY; TREATMENT OUTCOME; URETER OBSTRUCTION; WISTAR RAT;

ACETATES; ANIMALS; CREATININE; CYSTEINE; FIBROSIS; GLUTATHIONE; KIDNEY; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; PROTECTIVE AGENTS; QUINOLINES; RATS, WISTAR; RENAL INSUFFICIENCY; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; UREA; URETERAL OBSTRUCTION;

EID: 84930839006     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-5538.IBJU.2015.02.14     Document Type: Article

References (47)

1. Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M. Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin.Naunyn Schmiedebergs Arch Pharmacol. 2002;365:277-83.
2. Vaughan ED Jr, Sorenson EJ, Gillenwater JY. The renal hemodynamic response to chronic unilateral complete ureteral occlusion. Invest Urol. 1970;8:78-90.
3. Schreiner GF, Harris KP, Purkerson ML, Klahr S. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int. 1988;34:487-93.
4. Ricardo SD, Ding G, Eufemio M, Diamond JR. Antioxidant expression in experimental hydronephrosis: role of mechanical stretch and growth factors. Am J Physiol. 1997;272:F789-98.
5. Saborio P, Krieg RJ Jr, Kuemmerle NB, Norkus EP, Schwartz CC, Chan JC. Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr Nephrol. 2000;14:740-6.
6. Kawada N, Moriyama T, Ando A, Fukunaga M, Miyata T, Kurokawa K, et al. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 1999;56:1004-13.
7. Klahr S. Urinary tract obstruction. Semin Nephrol. 2001;21:133-45.
8. Huang HS, Ma MC, Chen CF, Chen J. Changes in nitric oxide production in the rat kidney due to CaOx nephrolithiasis. Neurourol Urodyn. 2006;25:252-8.
9. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000;71:1062-76.
10. Schubert SY, Neeman I, Resnick N. A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants. FASEB J. 2002;16:1931-3.
11. Aviram M, Dornfeld L, Kaplan M, Coleman R, Gaitini D, Nitecki S, et al. Pomegranate juice flavonoids inhibit lowdensity lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp Clin Res.2002;28:49-62.
12. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology. 1989;96:29-36.
13. Wallace JL, McKnight GW, Keenan CM, Byles NI, MacNaughton WK. Effects of leukotrienes on susceptibility of the rat stomach to damage and investigation of the mechanism of action. Gastroenterology. 1990;98:1178-86.
14. Wallace JL, Beck PL, Morris GP. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage? Am J Physiol. 1988;254:G117-23.
15. Damon M, Chavis C, Godard P, Michel FB, Crastes de Paulet A. Purification and mass spectrometry identification of leukotriene D4 synthesized by human alveolar macrophages. Biochem Biophys Res Commun. 1983 Mar 16;111:518-24.
16. Williams JD, Czop JK, Austen KF. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators. J Immunol.1984 Jun;132:3034-40.
17. Aharony D. Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med. 1998;157:S214-9.
18. O'Byrne PM. Asthma treatment: antileukotriene drugs. Can Respir J. 1998;5 Suppl A:64A-70A.
19. Wenzel SE. Leukotriene receptor antagonists and related compounds. Can Respir J. 1999;6:189-93.
20. Carsin H, Bargues L, Stéphanazzi J, Paris A, Aubert P, Le Béver H. [Inflammatory reaction and infection in severe burns]. Pathol Biol (Paris). 2002;50:93-101.
21. Konturek SJ, Brzozowski T, Drozdowicz D, Beck G. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats. Dig Dis Sci. 1988;33:806-13.
22. Sener G, Sakarcan A, Sehirli O, Eksioglu-Demiralp E, Sener E, Ercan F, et al. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast. Prostaglandins Other Lipid Mediat. 2007;83:257-67.
23. Wasowicz W, Nève J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39:2522-6.
24. Moron MS, Depierre JW, Mannervik B. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta. 1979;582:67-78.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-75.
26. Granger DL, Taintor RR, Boockvar KS, Hibbs JB Jr. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol. 1996;268:142-51.
27. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
28. Allen CT. Laboratory methods in histochemistry. In: Prophet EB, Mills B, Arrington JB, Sobin LH (eds). American registry of pathology, 1st edn. Washington DC. 1992; pp. 53.
29. Kinugasa F, Noto T, Matsuoka H, Urano Y, Sudo Y, Takakura S, et al. Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction. Transpl Immunol. 2010;23:18-23.
30. Canbay E, Agachan B, Ozturk T, Giris M, Asoglu O, Balik E, et al. Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses. Surg Innov. 2010;17:248-55.
31. Sener G, Sehirli O, Velioglu-Ogünç A, Cetinel S, Gedik N, Caner M, et al. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res. 2006;54:65-71.
32. Damtew B, Marino JA, Fratianne RB, Spagnuolo PJ. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med. 1993;121:328-36.
33. Wallace JL, Beck PL, Morris GP. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage? Am J Physiol. 1988;254(1 Pt 1):G117-23.
34. Carsin H, Bargues L, Stéphanazzi J, Paris A, Aubert P, Le Béver H. Inflammatory reaction and infection in severe burns. Pathol Biol (Paris). 2002;50:93-101.
35. Konturek SJ, Brzozowski T, Drozdowicz D, Beck G. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats. Dig Dis Sci. 1988;33:806-13.
36. Kabasakal L, Sener G, Cetinel S, Contuk G, Gedik N, Yegen BC. Burn-induced oxidative injury of the gut is ameliorated by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fatty Acids. 2005;72:431-40.
37. Turtay MG, Firat C, Samdanci E, Oguzturk H, Erbatur S, Colak C. Effects of montelukast on burn wound healing in a rat model. Clin Invest Med. 2010;33:E413-21.
38. Hashem RM, Soliman HM, Shaapan SF. Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. J Pharm Pharmacol. 2008;60:83-9.
39. Cheung RT, Tipoe GL, Tam S, Ma ES, Zou LY, Chan PS. Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration. J Pineal Res. 2006;41:337-43.
40. Pignone AM, Rosso AD, Fiori G, Matucci-Cerinic M, Becucci A, Tempestini A, et al. Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarcoidosis. J Pineal Res. 2006;41:95-100.
41. Basireddy M, Isbell TS, Teng X, Patel RP, Agarwal A. Effects of sodium nitrite on ischemia-reperfusion injury in the rat kidney. Am J Physiol Renal Physiol.2006;290:F779-86.
42. Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 2001;281:F948-57.
43. Erdogan H, Fadillioglu E, Yagmurca M, Uçar M, Irmak MK. Protein oxidation and lipid peroxidation after renal ischemiareperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res. 2006;34:41-6.
44. Rodríguez-Reynoso S, Leal C, Portilla-de Buen E, Castillo JC, Ramos-Solano F. Melatonin ameliorates renal ischemia/reperfusion injury. J Surg Res. 2004;116:242-7.
45. Singh D, Chander V, Chopra K. Carvedilol attenuates ischemia-reperfusion-induced oxidative renal injury in rats. Fundam Clin Pharmacol. 2004;18:627-34.
46. Singh D, Chopra K. Effect of trimetazidine on renal ischemia/reperfusion injury in rats. Pharmacol Res. 2004;50:623-9. Retraction in: Pharmacol Res. 2008;57:476.
47. Eschwège P, Paradis V, Conti M, Holstege A, Richet F, Detève J, et al. In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys. J Urol. 1999;162:553-7.